Research by DealForma
Decades of context backed by data from the DealForma database
Run your analyses better, in less time, with the newest database built for biopharma, medtech, and diagnostics.
Top Investors in Biotech Venture Rounds
Global biotechnology venture investment topped $11.8 billion in 258 financing rounds in the first 10 months of 2018. Who are the top biotech venture investors, where are they investing their money, and what are they investing in?
Biotech Companies in Major Industry Centers Rake in the Cash
Location, Location, Location: Real estate costs a lot in the three largest biotech hubs, but it’s a charm for raising capital. Biotech companies raised $37.4 billion globally in 1027 rounds of venture financing over the past four years from 2015 through the third quarter of 2018 and companies located in the San Francisco Bay Area, greater Boston area, and San Diego County accounted for 55 percent of the total raised and 46 percent of the financing activity.
Top 10 Biopharma Dealmakers by Upfront Cash
Pharma deal upfront cash payments made for development and commercialization with biotech, device, diagnostics, and technology platform companies.
Want data for your analysis? Want us to do it? Subscribers get both.
Schedule your demo of the DealForma database to see how we help you get better reports done faster.
22,968
Deal Profiles
12,034
Funding Rounds
23,805
Company Profiles
15,292
Product Profiles
119K+
Clinical Trials
3,386
Business Developers
Specifically for Biotech, Pharma, Device, and Diagnostics
You met on Zoom. Now it's Deal Time.
With thousands of company profiles and a decade of deals specifically in biopharma and medtech, you'll take the guesswork out of deal comps. Schedule your customized demo to see how DealForma helps you win that term sheet with better data.